Adtran today launched its Ensemble Cloudlet vRouter, a cloud-managed solution that enables providers to deliver high-performance Layer 3 managed services with less cost, complexity and risk. As traditional routers reach end-of-life and core network revenues remain flat, providers are looking to enterprise sites to drive new growth. Delivered through a single subscription, the new solution offers a lower-cost alternative to proprietary appliances while enabling smarter service delivery, faster r...
Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the HADLIMA™ (adalimumab-bwwd) high- and low-concentration (40 mg/0.4 mL, 40 mg/0.8 mL) autoinjectors and high-concentration prefilled syringe as interchangeable biosimilars to Humira® (adalimumab).2 These interchangeability designations follow the interchangeability designation received for the HADLIMA low-concentration (40 mg/0.8 mL) prefilled syringe and s...
Takeda (TSE:4502/NYSE:TAK) today announced that applications are now open for its Innovators in Science Award. This prestigious global award, originally launched in 2016, celebrates groundbreaking research with a focus on emerging scientific leaders who are advancing the frontiers of scientific discovery and fostering innovation that has the potential to transform lives. In 2026, the Takeda Innovators in Science Award with Nature will recognize promising early-career scientists in the areas of...
First Eagle Investments ("First Eagle") today announced the appointment of Rémi Casals as Executive Managing Director, Head of International Wealth Solutions (IWS). Casals leads the team responsible for the firm’s international wholesale distribution business, which comprises approximately $10 billion in assets through its partnership with Amundi Asset Management and its Ireland-based ICAV investment offerings. He joins the firm’s Partnership Committee and reports directly to Mehdi Mahmud, Pres...
To help organizations stay ahead of tightening data privacy regulations, Regula, a global developer of identity verification solutions, has extended its personal data masking functionality to Regula Forensic Studio (RFS), software that powers forensic devices. This new update helps document experts protect personal data with a single click, meeting growing privacy demands without disrupting workflows. This press release features multimedia. View the full release here: https://www.businesswire....
TreeFrog Therapeutics, a French biotech specializing in cell therapy has secured a €30 million financing from the European Investment Bank (EIB). The financing will support the advancement of their lead cell therapy program in Parkinson’s Disease to the clinic. Funds will also be used to reinforce their internal pipeline in other disease areas with large unmet needs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527015423/en/Vic...
REVEAL GENOMICS, S.L., a biotechnology company advancing precision oncology through biomarker innovation, today announced the presentation of four independent studies at the 2025 ASCO Annual Meeting. The studies, involving more than 800 patients, evaluated the clinical utility of its flagship test, HER2DX, in early-stage HER2-positive (HER2+) breast cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527779428/en/HER2DX studie...
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today released its "State of Cybersecurity Report 2025." The report underscores the growing importance of integrating AI into cybersecurity operations at a time of mounting cost pressures and increasingly sophisticated cyber threats. The report surveyed over 100 global cybersecurity leaders and consultants and found that AI-driven automation and cost optimization were among the main cyber...
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of TEVIMBRA® (tislelizumab), in combination with gemcitabine and cisplatin, for the first-line treatment of adult patients with recurrent, not amenable to curative surgery or radiotherapy, or metastatic NPC....
RHEACELL, a German biotech company specialized in the development of stem cell therapies, and AOP Health, a Europe-based leader in integrated therapies for rare diseases and in intensive care, are forming a strategic alliance. This partnership marks a crucial step toward making breakthrough therapies available to patients with high unmet medical needs – particularly those affected by Epidermolysis bullosa (EB or “butterfly children’s disease”) and chronic venous wounds. Both conditions currentl...